Skip to content
Open access

Technology profiles in FDA-approved new molecular entities, 2013–2024: a latent class analysis

Sep 2026 · DARU Journal of Pharmaceutical Sciences · Vol 34 · 0 citations · 25 references
Medicine
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.